Exact Mass: 396.3028

Exact Mass Matches: 396.3028

Found 89 metabolites which its exact mass value is equals to given mass value 396.3028, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

delta-Tocotrienol

(2R)-2,8-Dimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

C27H40O2 (396.3028)


delta-Tocotrienol, also known as 8-methyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the carbon C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, delta-tocotrienol is considered to be a quinone lipid molecule. delta-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. delta-Tocotrienol is found in American cranberry and palm oil. It is a nutriceutical with anticancer properties and a positive influence on the blood lipid profile. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. d-Tocotrienol is found in many foods, some of which are fennel, caraway, coconut, and lichee. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

2-methyl-6-geranylgeranyl-1,4-benzoquinol

2-methyl-6-geranylgeranyl-1,4-benzoquinol

C27H40O2 (396.3028)


   

delta3,5-Deoxytigogenin

(2R,4S,5R,7S,8R,9S,13R)-5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16,18-diene

C27H40O2 (396.3028)


delta3,5-Deoxytigogenin is found in fenugreek. delta3,5-Deoxytigogenin is isolated from Balanites aegyptiaca (soapberry tree fruits). Isolated from Balanites aegyptiaca (soapberry tree fruits). delta3,5-Deoxytigogenin is found in fruits and fenugreek.

   

alpha-Micropteroxanthin B

4-[(1E,3E,5E,7E,9E,11E)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11-hexaen-1-yl]-3,5,5-trimethylcyclohex-2-en-1-ol

C27H40O2 (396.3028)


alpha-Micropteroxanthin A is found in fishes. alpha-Micropteroxanthin A is isolated from integuments of black bass, Micropterus salmoides. Isolated from integuments of black bass, Micropterus salmoides. alpha-Micropteroxanthin B is found in fishes.

   

beta-Micropteroxanthin

4-[(1E,3E,5E,7E,9E,11E)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11-hexaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C27H40O2 (396.3028)


beta-Micropteroxanthin is found in fishes. beta-Micropteroxanthin is isolated from integuments of black bass Micropterus salmoides. Isolated from integuments of black bass Micropterus salmoides. beta-Micropteroxanthin is found in fishes.

   

9,12-Hexadecadienoylcarnitine

(3R)-3-[(9Z,12Z)-Hexadeca-9,12-dienoyloxy]-4-(trimethylazaniumyl)butanoic acid

C23H42NO4 (396.3114)


9,12-Hexadecadienoylcarnitine is an acylcarnitine. More specifically, it is an 9,12-hexadecadienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9,12-Hexadecadienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 9,12-hexadecadienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane.  Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

delta3,5-Deoxyneotigogenin

(2R,4S,5S,7S,8R,9S,13R)-5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16,18-diene

C27H40O2 (396.3028)


delta3,5-Deoxyneotigogenin is found in fenugreek. delta3,5-Deoxyneotigogenin is isolated from Trigonella foenum-graecum (fenugreek Isolated from Trigonella foenum-graecum (fenugreek). delta3,5-Deoxyneotigogenin is found in herbs and spices and fenugreek.

   

N-Oleoyl Asparagine

3-carbamoyl-2-(octadec-9-enamido)propanoic acid

C22H40N2O4 (396.2988)


N-oleoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Oleic acid amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Oleoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Oleoyl Asparagine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

(2R)-2,8-Dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C27H40O2 (396.3028)


   

Spirosta-3,5-diene

(2R,4S,7S,8R,9S,13R)-5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16,18-diene

C27H40O2 (396.3028)


Spirosta-3,5-diene is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). Spirosta-3,5-diene can be found in fenugreek, which makes spirosta-3,5-diene a potential biomarker for the consumption of this food product.

   
   

Topsentisterol D2

Topsentisterol D2

C27H40O2 (396.3028)


   

ACMC-20mpnd

ACMC-20mpnd

C27H40O2 (396.3028)


   

Cholest-5-en-23-yn-3beta-ol-7-one|Gelliusterol C

Cholest-5-en-23-yn-3beta-ol-7-one|Gelliusterol C

C27H40O2 (396.3028)


   
   

Calicoferol A

(22E)-(8S)-3-hydroxy-9,10-seco-1,3,5(10),22-cholestatetraen-9-one

C27H40O2 (396.3028)


   

22E-form-25,26,27-Trinor-3-oxocycloart-22-en-24-al

22E-form-25,26,27-Trinor-3-oxocycloart-22-en-24-al

C27H40O2 (396.3028)


   

parvifoliol F

parvifoliol F

C27H40O2 (396.3028)


   

Phyllofenone B

Phyllofenone B

C27H40O2 (396.3028)


   

(20R)-22E-cholesta-4,22-diene-3,6-dione

(20R)-22E-cholesta-4,22-diene-3,6-dione

C27H40O2 (396.3028)


   

Abscisterol A

Abscisterol A

C27H40O2 (396.3028)


   

(20S,22E)-cholesta-1,22-dien-18,20-oxido-3-one|ximaosteroid A

(20S,22E)-cholesta-1,22-dien-18,20-oxido-3-one|ximaosteroid A

C27H40O2 (396.3028)


   

δ-Tocotrienol

NCGC00253541-03_C27H40O2_(2R)-2,8-Dimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl]-6-chromanol

C27H40O2 (396.3028)


A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2 and 8 and a farnesyl chain at position 2.

   

delta-Tocotrienol_major

delta-Tocotrienol_major

C27H40O2 (396.3028)


   

25-hydroxy-16,17,23,24-tetradehydrovitamin D3 / 25-hydroxy-16,17,23,24-tetradehydrocholecalciferol

25-hydroxy-16,17,23,24-tetradehydrovitamin D3 / 25-hydroxy-16,17,23,24-tetradehydrocholecalciferol

C27H40O2 (396.3028)


   

(5Z,7E,23Z)-(3S)-9,10-seco-5,7,10(19),16,23-cholestapentaene-3,25-diol

(23Z)-25-hydroxy-16,17,23,24-tetradehydrovitamin D3 / (23Z)-25-hydroxy-16,17,23,24-tetradehydrocholecalciferol

C27H40O2 (396.3028)


   

(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-23-yne-3,25-diol

25-hydroxy-23,23,24,24-tetradehydrovitamin D3 / 25-hydroxy-23,23,24,24-tetradehydrocholecalciferol

C27H40O2 (396.3028)


   

N-oleoyl asparagine

N-(9Z-octadecenoyl)-asparagine

C22H40N2O4 (396.2988)


   

DIOSGENIN,DEHYDRO

(2R,4S,5R,7S,8R,9S,13R)-5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-16,18-diene

C27H40O2 (396.3028)


   

D3,5-Deoxyneotigogenin

(2R,4S,5S,7S,8R,9S,13R)-5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-16,18-diene

C27H40O2 (396.3028)


   

a-Micropteroxanthin b

4-[(1E,3E,5E,7E,9E,11E)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11-hexaen-1-yl]-3,5,5-trimethylcyclohex-2-en-1-ol

C27H40O2 (396.3028)


   

b-Micropteroxanthin

4-[(1E,3E,5E,7E,9E,11E)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11-hexaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C27H40O2 (396.3028)


   

Ximaosteroid E

5alpha-furosta-1,20(22)-dien-3-one

C27H40O2 (396.3028)


   

25-hydroxy-16,17,23,24-tetradehydrovitamin D3

(5Z,7E,23E)-(3S)-9,10-seco-5,7,10(19),16,23-cholestapentaene-3,25-diol

C27H40O2 (396.3028)


   

25-hydroxy-23,23,24,24-tetradehydrovitamin D3

(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-23-yne-3,25-diol

C27H40O2 (396.3028)


   

Sibogol D

3-hydroxy-9,10-seco-1,3,5(10)24-cholestatetraen-9-one

C27H40O2 (396.3028)


   

alpha-Micropteroxanthin A

(3S,6S)-11,12-Dihydro-10-apo-epsilon,psi-caroten-3,10-diol

C27H40O2 (396.3028)


   

Boc-D-Allylglycine dicyclohexylamine salt

Boc-D-Allylglycine dicyclohexylamine salt

C22H40N2O4 (396.2988)


   

Boc-L-2-allylglycine dicyclohexylamine salt

Boc-L-2-allylglycine dicyclohexylamine salt

C22H40N2O4 (396.2988)


   

(23Z)-25-hydroxy-16,17,23,24-tetradehydrovitamin D3/(23Z)-25-hydroxy-16,17,23,24-tetradehydrocholecalciferol

(23Z)-25-hydroxy-16,17,23,24-tetradehydrovitamin D3/(23Z)-25-hydroxy-16,17,23,24-tetradehydrocholecalciferol

C27H40O2 (396.3028)


   

2,8-dimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

2,8-dimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

C27H40O2 (396.3028)


   

[(2R)-3-carboxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

(4S,6R,7S,8R,9S,13R)-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-16,18-diene-6,2-oxane]

(4S,6R,7S,8R,9S,13R)-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-16,18-diene-6,2-oxane]

C27H40O2 (396.3028)


   

[3-carboxy-2-[(7Z,10Z)-hexadeca-7,10-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7Z,10Z)-hexadeca-7,10-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

[3-carboxy-2-[(3E,9E)-hexadeca-3,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,9E)-hexadeca-3,9-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

[3-carboxy-2-[(6E,9E)-hexadeca-6,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,9E)-hexadeca-6,9-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

[3-carboxy-2-[(2E,4E)-hexadeca-2,4-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,4E)-hexadeca-2,4-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

[3-carboxy-2-[(10E,12E)-hexadeca-10,12-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(10E,12E)-hexadeca-10,12-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

[3-carboxy-2-[(8E,10E)-hexadeca-8,10-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,10E)-hexadeca-8,10-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

4-amino-2-[[(E)-octadec-9-enoyl]amino]-4-oxobutanoic acid

4-amino-2-[[(E)-octadec-9-enoyl]amino]-4-oxobutanoic acid

C22H40N2O4 (396.2988)


   

[(1S)-3-carboxy-1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl]-trimethylazanium

[(1S)-3-carboxy-1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

[3-carboxy-2-[(4E,7Z)-hexadeca-4,7-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(4E,7Z)-hexadeca-4,7-dienoyl]oxypropyl]-trimethylazanium

C23H42NO4+ (396.3114)


   

beta-Micropteroxanthin

beta-Micropteroxanthin

C27H40O2 (396.3028)


   

alpha-Micropteroxanthin B

alpha-Micropteroxanthin B

C27H40O2 (396.3028)


   

Heptacosaheptaenoic acid

Heptacosaheptaenoic acid

C27H40O2 (396.3028)


   

NA-Arg 16:1(9Z)

NA-Arg 16:1(9Z)

C21H40N4O3 (396.31)


   

NA-Asn 18:1(9Z)

NA-Asn 18:1(9Z)

C22H40N2O4 (396.2988)


   

NA-Gln 17:1(9Z)

NA-Gln 17:1(9Z)

C22H40N2O4 (396.2988)


   

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C27H40O2 (396.3028)


   

25α-spirosta-3,5-diene

NA

C27H40O2 (396.3028)


{"Ingredient_id": "HBIN004598","Ingredient_name": "25\u03b1-spirosta-3,5-diene","Alias": "NA","Ingredient_formula": "C27H40O2","Ingredient_Smile": "CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC=C6)C)C)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "20191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

25β-spirosta-3,5-diene

NA

C27H40O2 (396.3028)


{"Ingredient_id": "HBIN004603","Ingredient_name": "25\u03b2-spirosta-3,5-diene","Alias": "NA","Ingredient_formula": "C27H40O2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "20192","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,3ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2s,3e,5s)-5-methylhept-3-en-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2s,3e,5s)-5-methylhept-3-en-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C27H40O2 (396.3028)


   

7-hydroxy-9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

7-hydroxy-9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C27H40O2 (396.3028)


   

1,6,6,9a,11a-pentamethyl-1-(4-oxopentan-2-yl)-2h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1,6,6,9a,11a-pentamethyl-1-(4-oxopentan-2-yl)-2h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H40O2 (396.3028)


   

2,6-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran-8-ol

2,6-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran-8-ol

C27H40O2 (396.3028)


   

n-[(3s,6s)-1-methyl-2-oxo-6-(tetradecanoyloxy)azepan-3-yl]carboximidic acid

n-[(3s,6s)-1-methyl-2-oxo-6-(tetradecanoyloxy)azepan-3-yl]carboximidic acid

C22H40N2O4 (396.2988)


   

1,1,4a,6a,7,11a-hexamethyl-3h,4h,4bh,5h,6h,6bh,7h,8h,10h,10ah,11h,13h,13ah-indeno[2,1-a]phenanthrene-2,9-dione

1,1,4a,6a,7,11a-hexamethyl-3h,4h,4bh,5h,6h,6bh,7h,8h,10h,10ah,11h,13h,13ah-indeno[2,1-a]phenanthrene-2,9-dione

C27H40O2 (396.3028)


   

2-methyl-6-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]benzene-1,4-diol

2-methyl-6-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]benzene-1,4-diol

C27H40O2 (396.3028)


   

(1'r,2s,2's,4'r,5s,7'r,8's,9'r,12's,13'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16',18'-diene

(1'r,2s,2's,4'r,5s,7'r,8's,9'r,12's,13'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16',18'-diene

C27H40O2 (396.3028)


   

5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16',18'-diene

5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16',18'-diene

C27H40O2 (396.3028)


   

(5as,5br,7as,8s,11as,11br,13s,13as,13br)-8-ethyl-13-hydroxy-5b,8,11a,13a-tetramethyl-5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-cyclopenta[a]chrysen-3-one

(5as,5br,7as,8s,11as,11br,13s,13as,13br)-8-ethyl-13-hydroxy-5b,8,11a,13a-tetramethyl-5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-cyclopenta[a]chrysen-3-one

C27H40O2 (396.3028)


   

2',6,6,9a-tetramethyl-5'-methylidene-2'-(4-oxopentan-2-yl)-2,4,5,5a,8,9-hexahydro-1h-spiro[cyclopenta[a]naphthalene-3,1'-cyclopentan]-7-one

2',6,6,9a-tetramethyl-5'-methylidene-2'-(4-oxopentan-2-yl)-2,4,5,5a,8,9-hexahydro-1h-spiro[cyclopenta[a]naphthalene-3,1'-cyclopentan]-7-one

C27H40O2 (396.3028)


   

(7e)-1-(2,8-dimethyl-4h-chromen-6-yl)-3,8,12-trimethyltrideca-7,11-dien-3-ol

(7e)-1-(2,8-dimethyl-4h-chromen-6-yl)-3,8,12-trimethyltrideca-7,11-dien-3-ol

C27H40O2 (396.3028)


   

n-[1-methyl-2-oxo-6-(tetradecanoyloxy)azepan-3-yl]carboximidic acid

n-[1-methyl-2-oxo-6-(tetradecanoyloxy)azepan-3-yl]carboximidic acid

C22H40N2O4 (396.2988)


   

2-methyl-6-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)benzene-1,4-diol

2-methyl-6-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)benzene-1,4-diol

C27H40O2 (396.3028)


   

9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C27H40O2 (396.3028)


   

(1s,5ar,9ar,9bs,11as)-1,6,6,9a,11a-pentamethyl-1-[(2r)-4-oxopentan-2-yl]-2h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1s,5ar,9ar,9bs,11as)-1,6,6,9a,11a-pentamethyl-1-[(2r)-4-oxopentan-2-yl]-2h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H40O2 (396.3028)


   

(2s)-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-6-ol

(2s)-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-6-ol

C27H40O2 (396.3028)


   

5-methyl-6-(5-methyl-4-methylidenehexylidene)-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadec-10-en-15-ol

5-methyl-6-(5-methyl-4-methylidenehexylidene)-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadec-10-en-15-ol

C27H40O2 (396.3028)


   

(2's,3r,5ar,9as)-2',6,6,9a-tetramethyl-5'-methylidene-2'-[(2r)-4-oxopentan-2-yl]-2,4,5,5a,8,9-hexahydro-1h-spiro[cyclopenta[a]naphthalene-3,1'-cyclopentan]-7-one

(2's,3r,5ar,9as)-2',6,6,9a-tetramethyl-5'-methylidene-2'-[(2r)-4-oxopentan-2-yl]-2,4,5,5a,8,9-hexahydro-1h-spiro[cyclopenta[a]naphthalene-3,1'-cyclopentan]-7-one

C27H40O2 (396.3028)


   

1,3a,6,6,9a-pentamethyl-1-(4-oxopentan-2-yl)-2h,3h,5h,5ah,8h,9h,9bh,10h-cyclopenta[a]phenanthren-7-one

1,3a,6,6,9a-pentamethyl-1-(4-oxopentan-2-yl)-2h,3h,5h,5ah,8h,9h,9bh,10h-cyclopenta[a]phenanthren-7-one

C27H40O2 (396.3028)


   

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C27H40O2 (396.3028)


   

(1r,3ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C27H40O2 (396.3028)


   

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C27H40O2 (396.3028)


   

(2s)-2,6-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-8-ol

(2s)-2,6-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-8-ol

C27H40O2 (396.3028)


   

(4ar,4bs,6ar,6bs,7r,10as,11ar,13ar)-1,1,4a,6a,7,11a-hexamethyl-3h,4h,4bh,5h,6h,6bh,7h,8h,10h,10ah,11h,13h,13ah-indeno[2,1-a]phenanthrene-2,9-dione

(4ar,4bs,6ar,6bs,7r,10as,11ar,13ar)-1,1,4a,6a,7,11a-hexamethyl-3h,4h,4bh,5h,6h,6bh,7h,8h,10h,10ah,11h,13h,13ah-indeno[2,1-a]phenanthrene-2,9-dione

C27H40O2 (396.3028)


   

(1s,2s,5s,6e,9s,13r,14r,15s)-5-methyl-6-(5-methyl-4-methylidenehexylidene)-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadec-10-en-15-ol

(1s,2s,5s,6e,9s,13r,14r,15s)-5-methyl-6-(5-methyl-4-methylidenehexylidene)-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadec-10-en-15-ol

C27H40O2 (396.3028)


   

(1s,3as,5as,9ar,9bs)-1,3a,6,6,9a-pentamethyl-1-[(2r)-4-oxopentan-2-yl]-2h,3h,5h,5ah,8h,9h,9bh,10h-cyclopenta[a]phenanthren-7-one

(1s,3as,5as,9ar,9bs)-1,3a,6,6,9a-pentamethyl-1-[(2r)-4-oxopentan-2-yl]-2h,3h,5h,5ah,8h,9h,9bh,10h-cyclopenta[a]phenanthren-7-one

C27H40O2 (396.3028)